FDA To Provide Updates On Agency Involvement In Critical Path Projects
This article was originally published in The Pink Sheet Daily
Executive Summary
Agency opportunities list highlights 76 “scientific projects” that could modernize the medical product development process.
You may also be interested in...
Von Eschenbach Disappointed With Critical Path Progress
FDA Commissioner tells Maryland biotech audience he wants FDA to be a bridge rather than a barrier to life science advances.
Von Eschenbach Disappointed With Critical Path Progress
FDA Commissioner tells Maryland biotech audience he wants FDA to be a bridge rather than a barrier to life science advances.
Gene Logic To Share Genomic Data With FDA For Critical Path Initiative
Voluntary collaboration will help FDA develop quality standards for submission of microarray data.